Overview

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.
Phase:
Phase 2
Details
Lead Sponsor:
Kyowa Kirin, Inc.
Treatments:
Aflibercept